MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

23andMe
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
John D. Loike | Aug 16, 2018
Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
First Direct-to-Consumer BRCA Test Authorized by FDA
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
The Rising Research Profile of 23andMe
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
FDA OKs Marketing of DTC Genetic Health-Risk Tests
FDA OKs Marketing of DTC Genetic Health-Risk Tests
Diana Kwon | Apr 7, 2017
23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.
Pooling Consumer Genetic Data, Researchers ID Links to Depression
Pooling Consumer Genetic Data, Researchers ID Links to Depression
Alison F. Takemura | Aug 2, 2016
Access to data from thousands of genotyping customers helped scientists detect novel associations with the disorder across the genome.